newsfilter.io

Farm Products — industry outlook

  • Period: 2026-09-28 to 2026-10-19
  • Events: 1
  • Generated: 2026-10-19T06:30:00.003Z

Egg Cycle Rebalancing and Market Fundamentals

The industry is currently in an oversupplied trough with conventional egg prices deemed unsustainable; while no company explicitly forecasts the precise bottom, signs of supply rebalancing are emerging. CALM notes that layer flock estimates have declined to 336–343 million birds (down 4 million), August hatch numbers fell ~12% YoY, and increased cancellations have been observed. Production estimates are averaging 19.9 million cases/month. Despite current oversupply, demand remains constructive with retail volumes up ~4% YTD, QSR servings up 2.4% YTD, and exports surging 29% YTD to their highest monthly volume since May 2023. Specialty segments like cage-free and organic are outpacing the broader category with 6% YTD growth. CALM expects pricing influence from conventional eggs to persist but acknowledges that current low levels require adjustment.

Capital Allocation and Strategic Expansion

Several companies are prioritizing capacity expansion and diversification over dividend distributions, with management viewing current losses as investments in future earnings power. CALM is executing a roadmap to increase prepared foods production capacity by >60% by H1 FY2028, including a high-speed pancake line adding ~12 million pounds annually in early FY2027, network optimization adding ~17 million pounds of scrambled egg capacity in FY2027, and a Kripini investment adding ~18 million pounds progressively through FY2028. This strategy involves $54 million in announced capital investment, with earnings contribution expected to accelerate in the back half of FY2027 as volume scales, aiming eventually for mid-teens operating margins. CALM has stated it will not pay cash dividends until a cumulative loss of $94.5 million is recovered, while simultaneously maintaining an aggressive share repurchase program with $315.7 million of a $500 million authorization remaining. The company also retains a virtually debt-free balance sheet with $767.6 million in cash to fund this roadmap and potential "bolt-on, tuck-in" M&A opportunities.

Input Cost Pressures and Operational Risks

Significant headwinds regarding input costs and biological risks are constraining near-term margins, with companies unable to fully offset volatile feed prices despite potential logistical relief. Feed costs remain elevated, rising 4.3% YoY for CALM, with USDA projections indicating potential 8% increases due to corn's 16% heavier weight in rations and tightness in soybean/corn stocks-to-use (9.5–10.5%). Logistics expenses for CALM have increased by >16%, with potential relief anticipated only if Middle East pricing normalizes. A major biological risk is the seasonal rise in Highly Pathogenic Avian Influenza (HPAI) linked to fall wild bird migration; early indicators include outbreaks in 7 states with turkeys (including Indiana) and commercial ducks in Canada, though no active layer outbreaks have been reported yet. CALM warns that weather delays in the Midwest harvest and grain tightness could keep input costs elevated longer than price adjustments materialize, compressing margins during the capacity ramp-up phase.